Lv4
680 积分 2021-08-25 加入
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
27天前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
27天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
27天前
已完结
Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients
27天前
已完结
Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer
1个月前
已完结
Urethroplasty for Radiotherapy Induced Bulbomembranous Strictures: A Multi-Institutional Experience
1个月前
已完结
Incidence of Urethral Stricture After Primary Treatment for Prostate Cancer: Data From CaPSURE
1个月前
已完结
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
2个月前
已完结
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
2个月前
已完结
Long-term follow-up after triple treatment of prostate cancer stage pT3
2个月前
已完结
皖公网安备34019202002308
